FFPE Whole-Genome Sequencing
Unlock high-quality genomic data from challenging clinical samples with our optimised low-input, degradation-tolerant pipeline.
The SMCL NGS Hub offers a robust whole-genome sequencing (WGS) pipeline for FFPE samples, addressing one of the most valuable yet technically challenging sources of clinical material. FFPE tissues represent a vast repository of clinically relevant samples, often linked to well-annotated patient cohorts and long-term outcomes. Our optimised pipeline is specifically designed to perform reliably on low-input and degraded DNA, enabling high-quality genomic data generation from challenging specimens. This capability unlocks the full potential of archival samples for biomarker discovery, translational research, and clinical studies, bringing previously inaccessible data into actionable insight.